Local delivery of accutox® synergises with immune-checkpoint inhibitors at disrupting tumor growth
J Transl Med. 2024 Jun 3;22(1):532. doi: 10.1186/s12967-024-05340-2. ABSTRACT BACKGROUND: The Accum® platform was initially designed to accumulate biomedicines in target cells by inducing endosomal-to-cytosol …